GI
CANO

Gradient Investments’s Cano Health, Inc. CANO Stock Holding History

Gradient Investments’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$6 – 1903
2023
Q4 		$6 Sell
1
-1
-50% -$12 ﹤0.01% 1818
2023
Q3 		$44 Hold
2
– – ﹤0.01% 1750
2023
Q2 		$240 Hold
2
– – ﹤0.01% 1620
2023
Q1 		$157 Hold
2
– – ﹤0.01% 1411
2022
Q4 		$237 Buy
+2
New +$677 ﹤0.01% 1367

Other funds holding CANO

SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GFPC
Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Gradient Investments's CANO Position: Q1 2024 in Review

Gradient Investments sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 1 share — an estimated $6 sold.

Gradient Investments first reported a position in CANO in Q4 2022 and held it in 5 quarters. The position peaked at $240 in Q2 2023. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Gradient Investments reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Gradient Investments sold 1 Cano Health, Inc. share in Q1 2024, an estimated $6.
  • Gradient Investments first reported a position in Cano Health, Inc. in Q4 2022 and held it in 5 quarters.
  • Gradient Investments's Cano Health, Inc. position peaked at $240 in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Gradient Investments's 13F filing for Q1 2024, filed 23 Apr 2024.